Raymond James Financial’s Kura Oncology KURA Stock Holding History

Raymond James Financial’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-314	Closed	-$1.81K	–	5907
2025 Q2	$1.81K	Buy	+314	New	+$1.92K	﹤0.01%	6435

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Raymond James Financial's KURA Position: Q3 2025 in Review

Raymond James Financial sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 314 shares — an estimated $1.81K sold.

Raymond James Financial first reported a position in KURA in Q2 2025 and held it in 1 quarter. The position peaked at $1.81K in Q2 2025. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

Raymond James Financial reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 314 Kura Oncology shares in Q3 2025, an estimated $1.81K.
Raymond James Financial first reported a position in Kura Oncology in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Kura Oncology position peaked at $1.81K in Q2 2025.
200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.